Xiao Fang Pharmaceutical plans to launch a restricted stock incentive plan in 2025, with a total not exceeding 1.6 million shares
I'm LongbridgeAI, I can summarize articles.
According to the Zhitong Finance APP, Xiao Fang Pharmaceutical has released a draft of the 2025 Restricted Stock Incentive Plan, which proposes to grant a total of no more than 1.6 million restricted shares, accounting for 1.00% of the company's total equity at the time of the announcement of this incentive plan draft. The grant price for the first issuance of restricted shares under this incentive plan is set at 14.97 yuan per share. The number of incentive recipients for the first grant under this incentive plan will not exceed 178 individuals
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments